ARCHIVES

Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review

This article is from The Cancer Letter archive.

Vol. 05 No. 02 | January 12, 1979

Download PDF Visit The Full Archive

Related Articles

In Brief: DCBD Board Adds Concept Review To Duties, Rabson Seeks Four Additional Member

September 19, 1980

Iressa Authorization In Europe Clarifies Differences Between U.S., E.U. Standards

July 31, 2009

Food & Water Inc. Launches ‘Cancer Prevention Campaign’

May 1, 1992

House Committee Gives NCI Only $6.5 Million Over President’s request

July 28, 1989

In Brief: Mark Kochevar Named New Administrative Officer Of DCE; Thomas Necheles Dies Suddenly at 51

September 21, 1984

Emory, Children’s Strengthen Ties

May 25, 2001